Trial Profile
Vitreous pge2 Level Changes After Topical Administration of Diclofenac 0.1%, Nepafenac 0.3%, Indomethacin 0.5% and Bromfenac 0.09% in Vitrectomy Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary) ; Diclofenac (Primary) ; Indometacin (Primary) ; Nepafenac (Primary)
- Indications Ocular inflammation
- Focus Pharmacokinetics
- 30 Jul 2018 New trial record